JOIN US FOR OUR THIRD ANNUAL

Hematology and Medical

Oncology Board Review:

Contemporary Practice from

Memorial Sloan Kettering

March 6-9, 2015

C O U R S E LO C AT I O N

Memorial Sloan Kettering Cancer Center

ZUCKERMAN RESEARCH CENTER
417 East 68th Street between First and York Avenues

NEW YORK

www.mskcc.org/
hemoncreviewcourse
To register and for more information, go to:

SCIENTIFIC AGENDA:

Hematology and Medical

Oncology Board Review:
Contemporary Practice from MSK
COURSE OVERVIEW
This four day course will provide an up-to-date and
comprehensive review of the diagnosis, staging, and
management of neoplastic disease, including solid tumor
and hematologic oncology. Lectures will focus on disease
specific topics in gastrointestinal, gynecologic, thoracic,
head and neck, genitourinary, soft tissue and skin, and
central nervous system oncology, as well as hematologic
oncology.

TARGET AUDIENCE
The target audience is physicians who are either
oncology fellows in training, or practicing oncologists in
both academic and private practice.

EDUCATIONAL OBJECTIVES
After this activity, participants will return to practice with
an understanding of the:
1. State-of-the-science in diagnosis, staging, and therapeutic
management of solid tumor cancers;
2. State-of-the-science in diagnosis, staging, and therapeutic
management of hematologic cancers;
3. Recent treatment advances in solid tumor and hematologic
oncology and their impact on modern clinical practice.

FOUR DAYS FEATURING:

State-of-the-science in diagnosis, staging, and

therapeutic management of solid tumor cancers;
State-of-the-science in diagnosis, staging, and
therapeutic management of hematologic cancers;
Recent treatment advances in solid tumor and
hematologic

www.mskcc.org/hemoncreviewcourse

SCIENTIFIC AGENDA:

Hematology and Medical

Oncology Board Review:
Contemporary Practice from MSK

COURSE DIRECTORS

David Ilson MD PhD

Attending Physician
Gastrointestinal Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Craig Moskowitz MD
Steven A. Greenberg Chair in Lymphoma Research
Clinical Director, Division of Hematologic Oncology
Attending Physician, Lymphoma and
Adult BMT Services
Member, Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Medical
College of Cornell University

MSK PHYSICIAN IN CHIEF

Jos Baselga MD PhD

Physician in Chief
Department of Medicine
Breast Medicine Service

www.mskcc.org/hemoncreviewcourse

SCIENTIFIC AGENDA:

Hematology and Medical

Oncology Board Review:
Contemporary Practice from MSK
COURSE FACULTY
Ghassan Abou-Alfa MD

Steven Horwitz MD

Carol Aghajanian MD

Clifford Hudis MD

Dean Bajorin MD

David Hyman MD

Associate Attending Physician

Gastrointestinal Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Attending Physician, Chief

Gynecologic Medical Oncology Svc, Department of
Medicine
Division of Solid Tumor Oncology

Attending Physician
Genitourinary Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

George Bosl MD

Attending Physician
Genitourinary Oncology Service
Department of Medicine
Division of Solid Tumor Oncology
Attending Physician, Chair
Department of Medicine

Paul Chapman MD
Attending Physician
Melanoma and Sarcoma Service
Department of Medicine
Division of Solid Tumor Oncology

Chau Dang MD

Associate Attending Physician

Breast Medicine Service
Division of Solid Tumor Oncology

Mark Dickson MD

Assistant Attending Physician

Sarcoma Medical Oncology Service
Division of Solid Tumor Oncology
Department of Mediciney

Sergio Andres Giralt MD

Attending Physician, Chief, Bone Marrow Transplant Service

Attending Physician, Lymphoma Service
Attending Physician, Acting Chief, Myeloma Service
Department of Medicine - Division of Hematologic
Oncology

Paul Hamlin MD

Assistant Attending Physician

Lymphoma Service
Department of Medicine
Division of Hematologic Oncology

Associate Attending Physician

Lymphoma Service
Department of Medicine
Division of Hematologic Oncology

Attending Physician, Chief

Breast Cancer Medicine Service
Department of Medicine
Division of Solid Tumor Oncology

Assistant Attending Physician

Gynecologic Medical Oncology Service, Division of
Solid Tumor Oncology, Department of Medicine

Lee M Krug MD

Associate Attending Physician

Thoracic Oncology Service
Division of Solid Tumor Oncolog
Department of Medicine

Simon Mantha MD
Associate Attending Physician
Hematology Service
Department of Medicine
Division of Hematologic Oncology

Michael Mauro MD
Attending Physician
Leukemia Service
Department of Medicine
Division of Hematologic Oncology

Robert Motzer MD
Attending Physician
Genitourinary Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Kenneth Offit MD
Attending Physician, Chief
Vice Chair for Academic Affairs
Clinical Genetics Service
Department of Medicine

Eileen OReilly MBBCh BAO

Associate Attending Physician
Gastrointestinal Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Antonio Omuro MD
Assistant Attending Neurologist
Neurology Service
Department of Neurology

www.mskcc.org/hemoncreviewcourse

SCIENTIFIC AGENDA:

Hematology and Medical

Oncology Board Review:
Contemporary Practice from MSK
COURSE FACULTY
Rekha Parameswaran MBBS
Associate Attending Physician
Hematology Service
Department of Medicine
Division of Hematologic Oncology
Associate Attending Physician
Blood Bank, Cytotherapy Lab Svc
Department of Laboratory Medicine

Jae Park MD

Assistant Attending Physician

Leukemia Service
Department of Medicine
Division of Hematologic Oncology

Miguel Perales MD
Associate Attending Physician
Bone Marrow Transplant Service
Department of Medicine
Division of Hematologic Oncology

David Pfister MD

Attending Physician, Chief

Head and Neck Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Maria Pietanza MD
Assistant Attending Physician
Thoracic Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Charles Rudin MD PhD

Attending Physician, Chief
Thoracic Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Leonard Saltz MD

Attending Physician, Chief

Gastrointestinal Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Paul Sabbatini MD

Attending Physician
Vice Chairman, Clinical Trials Office, Gynecologic
Medical Oncology Svc, Department of Medicine

Craig Sauter MD

Assistant Attending Physician

Bone Marrow Transplant Service
Department of Medicine
Division of Hematologic Oncology

Howard Scher MD
Attending Physician, Chief
Genitourinary Oncology Service
Department of Medicine

Andrew Seidman MD
Attending Physician
Breast Cancer Medicine Service
Department of Medicine
Division of Solid Tumor Oncology

Susan Seo MD

Associate Attending Physician

Infectious Disease Service
Department of Medicine
Division of General Medicine

Larry Smith MD
Assistant Attending,
Laboratory Medicine

Gerald Soff MD

Attending Physician, Chief

Hematology Service
Department of Medicine
Division of Hematologic Oncology
Attending Physician
Hematology Laboratory Service

Martin Tallman MD
Attending Physician, Chief
Leukemia Service
Department of Medicine
Division of Hematologic Oncology

Anas Younes MD

Attending Physician, Chief

Lymphoma Service
Department of Medicine
Division of Hematologic Oncology

Marjorie Zauderer MD
Assistant Attending Physician
Thoracic Oncology Service
Department of Medicine
Division of Solid Tumor Oncology

Andrew Zelenetz MD PhD

Attending Physician
Lymphoma Service
Department of Medicine
Division of Hematologic Oncology

www.mskcc.org/hemoncreviewcourse

SCIENTIFIC AGENDA:

Hematology and Medical

Oncology Board Review:
Contemporary Practice from MSK

Friday, March 6

Saturday, March 7

7:00-8:00am

REGISTRATION & BREAKFAST

7:00-8:00am

Medicine Grand Rounds

7:45-8:00am Mesothelioma

Colorectal Cancer:
Advanced Disease /
Adjuvant Therapy

8:00-8:45am

Ovarian Cancer

8:45-9:30am

Cervix / Uterine /
Other GYN Cancers

8:00-9:00am

Jos Baselga MD PhD

9:00-10:00am

Leonard Saltz MD
10:00-10:45am
10:45-11:30am
11:30am-12:15pm

12:15p-1:00pm
1:00-1:45pm
1:45-2:45pm

Prostate Cancer
Howard Scher MD

Marjorie Zauderer MD

Paul Sabbatini MD

Carol Aghajanian MD

9:30-10:15am

Breast Cancer
Adjuvant Therapy

Testis Cancer

George Bosl MD

Kidney Cancer

Robert Motzer MD
LUNCH

Urothelial Cancers

Chau Dang MD
10:15-10:30am

COFFEE BREAK

10:30-11:15am

Hepatobiliary Cancer

11:15am-12:00pm

Pancreatic Cancer /
Neuroendocrine
Cancer

Dean Bajorin MD

Non Small Cell Lung

Cancer: Advanced
Disease and Adjuvant
Therapy

Small Cell Lung Cancer

Lee M Krug MD

3:15-3:30pm

COFFEE BREAK

3:30-4:15pm

Cancer Genetics

4:15-5:00pm

Breast Cancer:
Advanced Disease

Kenneth Offit MD

Andrew Seidman MD
5:00-6:00pm Melanoma

Paul Chapman MD

Ghassan Abou-Alfa MD

Eileen OReilly MBBCh BAO

12:00-1:00pm

LUNCH

1:00-1:45pm

Gastric and
Esophageal Cancer

Charles Rudin MD PhD

2:45-3:15pm

BREAKFAST

David Ilson MD PhD

1:45-2:30pm

Head and Neck /

Thyroid Cancer
David Pfister MD

2:30-3:15pm

Pharmacology I

3:15-3:30pm

COFFEE BREAK

3:30-4:00pm
4:00-4:30pm

David Hyman MD

Pharmacology II

David Hyman MD

Central Nervous
System Cancers

Antonio Omuro MD

4:30-5:00pm Sarcoma

Mark Andrew Dickson MD

5:00-6:00pm

Infectious Disease

Susan Seo MD

www.mskcc.org/hemoncreviewcourse

SCIENTIFIC AGENDA:

Hematology and Medical

Oncology Board Review:
Contemporary Practice from MSK

Sunday, March 8

7:00-8:00am

BREAKFAST

8:00-8:30am

Chronic Lymphocytic
Leukemia / Small
Lymphocytic
Lymphoma and Hairy
Cell Leukemia
Jae Park MD

3:15-3:45pm

Hematopoietic Stem
Cell Transplantation
(Autologous /
Allogeneic)
Sergio Giralt MD

3:45-4:15pm

Complications of
Hematopoietic Stem
Cell Transplantation

8:30-9:00am Myelodysplastic

Syndromes and
Myeloproliferative
Disorders

Michael Mauro MD
9:00-9:45am

Acute Myelogenous
Leukemia and Acute
Lymphoblastic
Leukemia
Martin Tallman MD

9:45-10.00am

COFFEE BREAK

10:00-11:00am

Multiple Myeloma

11:00-11:45am

C. Ola Landrgren MD PhD

T-Cell / Cutaneous
Lymphoma
Steven Horwitz MD

1:30-2:00pm
2:00-2:30pm

Monday, March 9

7:00-8:00am

BREAKFAST

8:00-8:45am

Interpretation of
Coagulation Testing
Larry Smith MD

8:45-9:30am

Approach to the
Bleeding Patient

Rekha Parameswaran MD

9:30-10:15am Thrombosis:

Pathophysiology and
Management

Indolent Lymphomas

Andrew Zelenetz MD PhD

11:45am-1:00pm LUNCH
1:00-1:30pm

Miguel Perales MD

Gerald Soff MD
10:15-10:30am

COFFEE BREAK

10:30-11:15am Thrombocytopenia

Gerald Soff MD

11:15-11:30am

Update on Use of
The New Oral
Anticoagulants

Hodgkin Lymphoma

Craig Moskowitz MD

Aggressive Lymphomas
(Diffuse Large B- Cell
Lymphoma and Mantle
Cell Lymphoma)

Simon Mantha MD

11:30am-12:00pm CLOSING REMARKS

Paul Hamlin MD

2:30-3:00pm

Mantle Cell Lymphoma

and Waldenstrms
Macroglobulinemia
Anas Younes MD

3:00-3:15pm

COFFEE BREAK

www.mskcc.org/hemoncreviewcourse

REGISTRATION

$1,400.00 MDs, PhDs and DOs

$ 875.00 Fellows, Residents and RNs
Registration fee includes an electronic syllabus and other related hand-out materials,
continental breakfast, lunch, and refreshment breaks. Special meals are available
upon request, including vegetarian, kosher, or gluten-free. Please let us know if
we can assist you with special dietary needs. The course will be held on the campus of
Memorial Sloan Kettering on the Upper East Side of Manhattan. Breakfast and lunch
will be provided daily.
To register to attend please go to:

www.mskcc.org/hemoncreviewcourse
Or contact:

OFFICE OF CONTINUING MEDICAL EDUCATION

Memorial Sloan Kettering Cancer Center

633 Third Avenue, 12th floor, New York, New York 10017

(646) 227-2025 | brodheap@mskcc.org

TARGET AUDIENCE

Radiologist and Nuclear Medicine Physicians

who interpret oncologic FDG PET/CT.
COURSE DESIGN

This course is comprised of lectures

and interactive audience participation
encouraging the intellectual exchange of
ideas between faculty and participants.
EVALUATION

A course evaluation survey sent out

electronically will provide attendees with
the opportunity to review the sessions
and the speakers and to identify future
educational needs.
AMA CREDIT DESIGNATION STATEMENT

MSK designates this live activity for a

maximum of 26.25 AMA PRA Category
1 Credits. Physicians should only claim
credit commensurate with the extent of their
participation in the activity. The AMA has
determined that physicians not licensed in
the United States but who participate in this
CME activity are eligible for 26.25 AMA
PRA Category 1 Credits.
ACCREDITATION STATEMENT

MSK is accredited by the Accreditation

Council for Continuing Medical Education
(ACCME) to provide continuing medical
education for physicians.

FACULTY DISCLOSURE

It is the policy of MSK to make every

effort to insure balance, independence,
objectivity, and scientific rigor in all
continuing medical education activities
which it sponsors as an ACCME accredited
provider. In accordance with ACCME
guidelines and standards, all faculty
participating in an activity sponsored
by MSK are expected to disclose any
significant financial interest or other
relationship with the manufacturer(s)
of any commercial product(s) and/or
provider(s) of commercial services which
are discussed by the faculty members in
an educational presentation. As required
by the ACCME, when an unlabeled use of
a commercial product or an investigational
use not yet approved for any purpose is
discussed during an educational activity,
MSK requires the speaker to disclose that
the product is not labeled for the use
under discussion or that the product is still
investigational.
OUTCOMES MEASUREMENT SURVEY

Six months after the end of the course

an Outcomes Measurement Survey will
be sent to all participants to help us
determine what positive impacts have
been made on participant practice as a
result of the course.